The value of the partnership between Liquenia Treatment and the Nixarian Foundation
The Nixarian Foundation, a non-profit organization dedicated to raising awareness and conducting research into Vulvar Lichen Sclerosus and other similar vulvar conditions, entered into a collaboration agreement on February 15, 2022 with the medical team responsible for offering the following treatment in Spain.
Liquenia Treatment © Liquenia Treatment ©.
.
The importance of this agreement for the Nixarian Foundation lies in the fact that, through this collaboration, the Foundation will receive donations equal to 2% of the turnover from Liquenia Treatments performed during the year. This represents an important source of income for the organization, enabling it to continue and expand its outreach and research work, with the ultimate goal of helping more women affected by Vulvar Lichen Sclerosus.
Liquenia Treatment improves patients’ quality of life.
Vulvar Lichen Sclerosus is a little-known condition that affects a large number of women of all ages. In most cases, it is not diagnosed correctly, so affected women do not receive appropriate treatment, which can lead to serious complications such as vulvar cancer.
This collaboration agreement will help the Nixarian Foundation reach more affected women and therefore improve the detection, diagnosis, and treatment of Vulvar Lichen Sclerosus. In addition, Liquenia Treatment is one of the most effective treatments for this condition, so patients will be able to benefit directly from a high-quality treatment while also contributing to an altruistic cause.
The importance of research
The signing of this collaboration agreement will also enable the Nixarian Foundation to fund new research into Vulvar Lichen Sclerosus, contributing to advances in understanding and treating the condition. The organization will be able to launch medical studies, identify biomarkers, compare different treatments, and conduct clinical trials to improve the quality of life of affected women.
The Nixarian Foundation continues to seek new agreements
The Nixarian Foundation aims to continue working in collaboration with key stakeholders in the pharmaceutical industry, and more specifically in regenerative medicine, in order to help more women affected by Vulvar Lichen Sclerosus. The organization continues to seek new agreements that will enable it to increase its research and outreach capacity, improve detection, achieve earlier diagnoses, and provide lichen treatment to more women at risk of social exclusion who suffer from this condition.
In conclusion, the collaboration agreement signed between the Nixarian Foundation and the medical team responsible for Liquenia Treatment is an important step towards improving the situation of women affected by Vulvar Lichen Sclerosus. This agreement will contribute to funding new research, improve the detection, diagnosis, and treatment of the condition, and directly benefit users by enabling access to high-quality treatments.
